← Leaderboards
Kenneth A Newell
University Of Chicago
$10,287,872
Attributed
$11,455,550
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,455,550 · 6
By mechanism
U01$6,287,561 · 2
R01$5,167,989 · 4
Top collaborators
- Stephen Pastan9 shared
Most similar at University Of Chicago
Same institution · by research overlap
- William F Parker$2,212,434
Others in their field
Top investigators on “Allografting”
- Peter Scott Heeger · Case Western Reserve University$89,944,691
- Joren C Madsen · Massachusetts General Hospital$64,077,296
- Mohamed H Sayegh · University Of Pennsylvania$37,064,374
- Peter G Stock · University Of California San Francisco$34,726,786
- Stuart Johnston Knechtle · University Of Wisconsin Madison$29,542,758
- Angus W Thomson · University Of Pittsburgh At Pittsburgh$28,254,094
Research focus
AllograftingTransplantationPrevalenceKidney TransplantationTransplant RecipientsKidneyVirus DiseasesReportingProgramsImmunosuppressive AgentsInfectionAntibodiesOrganKidney AllograftKidney DiseasesProspectiveBiopsyInjuryGraft SurvivalRenal FunctionGenesGastrointestinal TransplantationGeneticAfrican American
Grant awards (27)
8/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$267,383
U01 · FY2025 · DK
8/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$277,552
U01 · FY2024 · DK
8/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$372,000
U01 · FY2023 · DK
Studying APOL1 Following Transplantation (SAF-T): the Emory APOLLO Clinical Center Consortium$306,451
U01 · FY2022 · DK
Studying APOL1 Following Transplantation (SAF-T): the Emory APOLLO Clinical Center Consortium$133,332
U01 · FY2020 · DK
Studying APOL1 Following Transplantation (SAF-T): the Emory APOLLO Clinical Center Consortium$346,142
U01 · FY2019 · DK
Studying APOL1 Following Transplantation (SAF-T): the Emory APOLLO Clinical Center Consortium$269,852
U01 · FY2018 · DK
Studying APOL1 Following Transplantation (SAF-T): the Emory APOLLO Clinical Center Consortium$84,825
U01 · FY2018 · DK
Studying APOL1 Following Transplantation (SAF-T): the Emory APOLLO Clinical Center Consortium$277,820
U01 · FY2017 · DK
Preserving Renal Function & Protective Immunity Via Anti-LFA1-Based CNI Avoidance$1,978,098
U01 · FY2013 · AI · contact PI
Preserving Renal Function & Protective Immunity Via Anti-LFA1-Based CNI Avoidance$1,974,106
U01 · FY2012 · AI · contact PI
Pathogenesis of Murine Polyomavirus Allograft Nephropathy$379,789
R01 · FY2012 · AI · contact PI
Pathogenesis of Murine Polyomavirus Allograft Nephropathy$379,789
R01 · FY2011 · AI · contact PI
Pathogenesis of Murine Polyomavirus Allograft Nephropathy$383,625
R01 · FY2010 · AI · contact PI
Pathogenesis of Murine Polyomavirus Allograft Nephropathy$387,500
R01 · FY2009 · AI · contact PI
Graft-specific factors promoting intestinal rejection$355,788
R01 · FY2009 · AI · contact PI
Pathogenesis of Murine Polyomavirus Allograft Nephropathy$386,771
R01 · FY2008 · AI · contact PI
Graft-specific factors promoting intestinal rejection$355,788
R01 · FY2008 · AI · contact PI
Graft-specific factors promoting intestinal rejection$362,679
R01 · FY2007 · AI · contact PI
Graft-specific factors promoting intestinal rejection$373,511
R01 · FY2006 · AI · contact PI
Graft-specific factors promoting intestinal rejection$382,500
R01 · FY2005 · AI
T CELL Costimulation in Intestinal Allograft Rejection$304,000
R01 · FY2004 · AI
T CELL Costimulation in Intestinal Allograft Rejection$304,000
R01 · FY2003 · AI
T CELL Costimulation in Intestinal Allograft Rejection$304,000
R01 · FY2002 · AI
T CELL Costimulation in Intestinal Allograft Rejection$289,146
R01 · FY2001 · AI
INTESTINAL ALLOGRAFT REJECTION--MECHANISMS AND THERAPIES$138,864
R01 · FY2000 · AI
INTESTINAL ALLOGRAFT REJECTION--MECHANISMS AND THERAPIES$80,239
R01 · FY2000 · AI